NCT02341794

Rosuvastatin Treatment for Intracranial Arterial Stenosis Based on Magnetic Resonance Angiography

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Tokyo Medical University · Academic / Other
• Sex: All
• Age: 30 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to investigate the effects of rosuvastatin treatment on degree of intracranial arterial stenosis.

Detailed description

The purpose of this study is to investigate the effects of rosuvastatin treatment on degree of intracranial arterial stenosis in two years. Dyslipidemia patients with intracranial arterial stenosis will be enrolled under informed consent in this study. Rosuvastatin (5mg) will be orally administered once daily. Dose of rosuvastatin will be adjusted to control serum LDL-c level under 1.8mmol/L. Primary outcome is the progression of intracranial stenosis on magnetic resonance angiography (MRA) after two years.

Conditions

• Intracranial Arterial Diseases

Interventions

Type	Name	Description
DRUG	Rosuvastatin	Rosuvastatin (5mg) will be orally administrated once daily. Dose of rosuvastatin will be adjusted to control serum LDL-c level under 1.8 mmol/L.

Timeline

• Start date: 2015-01-01
• Primary completion: 2017-12-01
• Completion: 2018-07-01
• First posted: 2015-01-19
• Last updated: 2015-01-21

Locations

1 site across 1 country: Japan